Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...

Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner.

Beyond improving accuracy, xAI allowed researchers to compare prognostic markers across different cancer types, unveiling ...

One of the biggest challenges in cancer treatment is addressing the ability of cancer cells to adapt and become resistant, ...

Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

At least one kind of tumor marker other than CA 125 level was abnormally elevated in 18 (90%) of 20 patients from groups IIa and IIb, but in only two (6%) of 32 patients from groups III ...

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in various tumor cells in vitro, but its physiological role in tumor surveillance remains unknown. Here, we report ...

Real-world use of supportive medications to prevent and manage key adverse events during first-line (1L) treatment of metastatic pancreatic adenocarcinoma (mPDAC) with FOLFIRINOX (FFX), FFX without ...

Imaging, including transvaginal ultrasound or non-invasive abdominal imaging may reveal the tumor. A biopsy is the method of definitive diagnosis. Cancer markers like CA-125, HE4, and CA-19-9 might be ...

PROX1+ cells in intestinal adenomas of ApcMin/+ mice expressed intestinal epithelial and CRC stem cell markers, and cells with high PROX1 expression could both self-renew tumor stem/progenitor cells ...